JAK inhibitors Transcript
So, we've been working on this class of drugs [JAK inhibitors] now for about 5 or 6 years, both in our research...
So, we've been working on this class of drugs [JAK inhibitors] now for about 5 or 6 years, both in our research...
On the heels of his study, Dr. James Berenson an oncologist specializing in multiple myeloma —announced his latest...
Multiple myeloma (MM) patients are at higher risk for severe COVID-19. Their mRNA vaccination response against...